Skip to content

Clinical trials

Neoplasms, Glandular and Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20072
20082
20093
20103
20113
20122
20132
20142
20152
20165
20172
20183
20197
20205
20214
20226
20233
20241
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Unknown status10
Terminated9
Recruiting8
Active, not recruiting6
Not yet recruiting2
Enrolling by invitation1
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation3
Royal Marsden NHS Foundation Trust3
Sumitomo Pharma America, Inc.3
Assistance Publique - Hôpitaux de Paris2
Catalysis SL2
Merck Sharp & Dohme LLC2
National Cancer Institute (NCI)2
Revolution Medicines, Inc.2
Syndax Pharmaceuticals2
Xiaoxiang Chen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial66
Neoplasms47
Neoplasms by Histologic Type40
Carcinoma38
Neoplasms by Site33
Adenocarcinoma26
Digestive System Neoplasms23
Digestive System Diseases18
Urogenital Neoplasms15
Ovarian Neoplasms12

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.